Neurology Alert (Vol. 36, No. 1) - September 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: September 2016

Valid through: September 2019

Target Audience

This activity is intended for the neurologist.

Subjects

  • Impulse Control Disorders in Parkinson’s: Are All Dopamine Agonists Equal Offenders?
  • Neuropathy in Myeloma
  • Association of Traumatic Brain Injury with Late-life Neurodegenerative Diseases
  • Functional MRI in REM Behavior Disorder Is Suggestive of Future Parkinson’s Disease
  • Distinct EEG Features May Help Prognostication of Patients with Early PAMM
  • Community Education Improves Stroke Awareness and Appropriate Emergency Response
  • Triage to a Certified Stroke Center Reduces Early Mortality

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Claire Henchcliffe, MD, PhD, Associate Professor of Neurology and Neuroscience, Weill Cornell Medical College

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Nitin K. Sethi, MD, Associate Professor of Neurology, Weill Cornell Medical College

Alan Z. Segal, MD, Associate Professor of Clinical Neurology, Weill Cornell Medical College

Peter B. Forgacs, MD, Instructor in Neuroscience and Neurology, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medical College; Instructor in Clinical Investigation, The Rockefeller University, New York

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

:Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Claire Henchcliffe, MD, PhD, reports she is on the speakers bureau and advisory boards for Teva, IMPAX, and ACADIA; is on the advisory board for U.S. World Meds; and is a consultant for Cynapsus and Pfizer.

Authors Michael Rubin, MD, Nitin K. Sethi, MD; Alan Z. Segal, MD; and Peter B. Forgacs, MD report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.